Evasion of P53-mediated Growth Control Occurs by Three Alternative Mechanisms in Transformed Thyroid Epithelial Cells
Overview
Affiliations
Using the thyroid as a model of multistep epithelial tumorigenesis, we have used representative cell lines to correlate the degree of malignant transformation with the functional status of p53 and the integrity of cell-cycle check-points. Three distinct phenotypes were observed: Type I lines, derived from poorly-differentiated human thyroid cancers, expressed high levels of mutant p53 protein; Type II, also poorly-differentiated but derived from rat, showed over-expression of wild-type (wt) p53 with marked cell-cell heterogeneity: Type III, from well-differentiated human cancers, contained uniformly low levels of wt p53. All cell lines containing wt p53 retained a near-normal induction of p53 by DNA damage. However, the ability to undergo growth arrest differed strikingly. Whereas Type I and II lines had lost both G2/M and G1/S check points, Type III cells retained both. In Type III cells, as in diploid human fibroblasts, mutant p53 expression specifically abrogated G1/S check-point function with no other change in phenotype. These data demonstrate 3 mechanisms for evasion of p53 growth control: (i) direct mutation (ii) indirect inactivation, or (iii) 'avoidance' of activation, most probably due to failure to reach a critical threshold of DNA damage.
Intracellular cGMP increase is not involved in thyroid cancer cell death.
Alessandro S, Paradiso E, Lazzaretti C, Sperduti S, Perri C, Antoniani F PLoS One. 2023; 18(3):e0283888.
PMID: 36996255 PMC: 10062617. DOI: 10.1371/journal.pone.0283888.
Pilli T, Prasad K, Jayarama S, Pacini F, Prabhakar B Thyroid. 2009; 19(12):1333-42.
PMID: 20001716 PMC: 2833173. DOI: 10.1089/thy.2009.0195.
Ribeiro F, Meireles A, Rocha A, Rodrigues Teixeira M BMC Cancer. 2008; 8:371.
PMID: 19087340 PMC: 2651892. DOI: 10.1186/1471-2407-8-371.
Huang G, Hobbs S, Walton M, Epstein R Br J Cancer. 2002; 86(7):1104-9.
PMID: 11953857 PMC: 2364174. DOI: 10.1038/sj.bjc.6600219.
Immunohistochemical detection of p53 in Wilms' tumors correlates with unfavorable outcome.
Lahoti C, Thorner P, Malkin D, Yeger H Am J Pathol. 1996; 148(5):1577-89.
PMID: 8623926 PMC: 1861544.